Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.77
Delayed Data
As of 3:59pm ET
 +0.12 / +2.58%
Today’s Change
3.11
Today|||52-Week Range
8.10
-14.36%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.65
Today’s open4.63
Day’s range4.50 - 4.85
Volume36,439
Average volume (3 months)58,229
Market cap$118.2M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book14.38

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp-0.03-0.75%
CDTXCidara Therapeutics ...-0.04-0.34%
IBIOIbio Inc+0.01+1.52%
MTPMidatech Pharma PLC+0.02+0.70%
Data as of 4:01pm ET, 07/27/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers

Search for Jobs